Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3012 L-94901
The first organ-selective thyromimetic, lowering plasma low density lipoprotein (LDL) cholesterol and raising plasma high density lipoprotein (HDL) cholesterol levels
More description
DCC3011 L-870812
Novel inhibitor of HIV-1 and SIV integrase
More description
DCC3010 L-858051
Chemically-modified forskolin with greater stability and water solubility than the parent compound
More description
DCC3009 L-841411
Novel HIV-1 integrase strand transfer inhibitor (INSTI), stabilizing an integrase-single blunt-ended DNA complex
More description
DCC3007 L-770644
Potent and selective agonist of the human beta3 adrenergic receptor
More description
DCC3006 L-768673
Class III antiarrhythmic agent, selectively blocking the slowly activating cardiac delayed rectifier potassium current Iks
More description
DCC3005 L-749329
Dual ET(A)/ET(B) endothelin receptor antagonist
More description
DCC3004 L-744832
Ras farnesyltransferase inhibitor, inhibiting in p70(s6k) phosphorylation in mammary tumors, inducing tumor regression in transgenic mice by mediating alterations in both cell cycle control and apoptosis
More description
DCC3003 L-739758
Potent glycoprotein IIb/IIIa inhibitor
More description
DCC3002 L-735821
Inhibitor of the KCNQ1 channel
More description
DCC3001 L-731988
Inhibitor of Strand Transfer, Preventing Integration and Inhibiting HIV-1 Replication in Cells
More description
DCC3000 L-708906
Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1)
More description
DCC2999 L-696229
HIV-1 non-nucleoside reverse transcriptase inhibitor
More description
DCC2998 L-687306
Novel partial agonist of muscarinic M1 receptors
More description
DCC2997 L-682679
HIV protease inhibitor
More description
DCC2996 L-680833
Potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase (PMNL-E)
More description
DCC2995 L-663581
Novel partial agonist of the benzodiazepine receptor
More description
DCC2994 L-658758
Blocker of the activity of human neutrophil elastase (NE), human proteinase-3, human macrophage metalloelastase, mouse macrophage metalloelastase and Pseudomonas aeruginosa elastase
More description
DCC2993 L-651392
Potent leukotriene inhibitor
More description
DCC2992 L61h46
Novel potent inhibitor of human pancreatic cancer cells
More description
DCC2991 L524-0366
Novel inhibitor of the TWEAK-Fn14 signaling cascade
More description
DCC2990 L465046 (α-synuclein Amyloid Aggregation Inhibitor)
Novel inhibitor of α-synuclein amyloid aggregation for the treatment of Parkinson's disease
More description
DCC2989 L458-bpyne
Novel γ-secretase modulator photoaffinity probe, identifying distinct allosteric binding sites on presenilin that can be exploited to reduce levels of pathogenic Aβ species
More description
DCC2988 L2-4048
Novel Migration Inhibitory Factor (MIF) inhibitor, binding at the allosteric and tautomerase sites, blocking MIF's tautomerase CD74 receptor binding, and pro-inflammatory activities
More description
DCC2987 L17er4
Novel cell-permeable attenuated cationic amphiphilic lytic (ACAL) peptide, efficiently bring immunoglobulin G (IgG) and other functional proteins into cells
More description
DCC2986 L-162782
Nonpeptide agonist of angiotensin AT1 receptor
More description
DCC2985 L-161240
Potent inhibitor of LpxC and lipid A biosynthesis
More description
DCC2984 Kys05047
Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells
More description
DCC2983 Kya1797
Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres
More description
DCC2982 Ky1022
Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X